Product
VCN-01
1 clinical trial
2 indications
Indication
Pancreatic adenocarcinomaIndication
MetastaticClinical trial
A Phase IIb, Open-label, Randomized Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-04-28